Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape

BACKGROUND: The epidermal growth factor receptor (EGFR) is a therapeutic target for non-small cell lung cancer (NSCLC), but knowledge on gene mutations that contribute to NSCLC development and persistence is lacking. In this study, we investigated genetic variations in EGFR and their association wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Wei, Mao, Wenjun, Chen, Ruo, Lu, Rongguo, Liu, Feng, He, Yijun, Wang, Shengfei, Li, Xiaomin, Zheng, Mingfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880631/
https://www.ncbi.nlm.nih.gov/pubmed/31746315
http://dx.doi.org/10.12659/MSM.920042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880631/
https://www.ncbi.nlm.nih.gov/pubmed/31746315
http://dx.doi.org/10.12659/MSM.920042

Ejemplares similares